| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.06B | +10.8% |
| Cost of Revenue | $6.73B | +18.0% |
| Gross Profit | $7.32B | +5.0% |
| R&D Expense | $65.0M | -1.5% |
| SG&A Expense | $4.64B | +11.8% |
| Operating Income | $2.60B | -10.0% |
| Interest Expense | $693.0M | +38.6% |
| Pre-tax Income | $1.72B | -38.6% |
| Income Tax | $284.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $535.0M | -5.6% |
| Accounts Receivable | $1.48B | +29.3% |
| Inventory | $1.31B | +47.0% |
| Current Assets | $3.80B | +24.4% |
| Total Assets | $51.84B | +2.4% |
| Current Liabilities | $8.08B | +24.5% |
| Long-term Debt | $11.57B | -1.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.84B | -1.3% |
| Capital Expenditures | $353.0M | -16.5% |
| Investing Cash Flow | -$1.14B | -640.5% |
| Financing Cash Flow | -$1.73B | +37.4% |
| Free Cash Flow | $2.48B | +1.3% |
| -56.5% |
| Net Income | $1.44B | -33.1% |
| EPS (Basic) | $1.01 | -33.6% |
| EPS (Diluted) | $1.01 | -32.7% |
| Total Liabilities |
| $26.71B |
| +4.2% |
| Stockholders' Equity | $25.13B | +0.6% |